Letters in Drug Design & Discovery
Volume 18, 12 Issues, 2021
ISSN: 1875-628X (Online)
ISSN: 1570-1808 (Print)
This journal supports open access
ISSN: 1875-628X (Online)
ISSN: 1570-1808 (Print)
This journal supports open access
Contents
Letters in Drug Design & Discovery, Volume 2 - Number 8
Rational Design of the New Antihypertensive I1-Receptor Ligand 2-(2- Biphenyl-2-yl-1-methyl-ethyl)-4,5-dihydro-1H-imidazole
, 2(8): 571 - 578F. Gentili, P. Bousquet, A. Carrieri, J. Feldman, F. Ghelfi, M. Giannella, A. Piergentili, W. Quaglia, C. Vesprini and M. Pigini
DOI: 10.2174/157018005774717325
Docking Study, Synthesis and SAH-Hydrolase Inhibitory Activity of LAdeninylalanine and Related Analogues
, 2(8): 579 - 583Nicolas Floquet, Samuel Leroy, Murielle Muzard, Georges Guillerm and Jean-Bernard Behr
DOI: 10.2174/157018005774717262
Anti-tumour Activity of Some Polydentate N-Ligands: N,N-bis-(3- Substituted-5-Methylpyrazol-1yl Methyl) Arylamines and N,N,N,N-Tetra- [(3-Substituted-5-Methylpyrazol-1yl] Para-Phenylenediamines
, 2(8): 584 - 589T. B. Hadda, A. T. Kotchevar, M. Daoudi, B. Bennani, N. B. Larbi and A. Kerbal
DOI: 10.2174/157018005774717299
Discovery of Thrombin Inhibitor Fragments from Chemical Microarray Screening
, 2(8): 590 - 594Thomas Neumann, Hans-Dieter Junker, Oliver Keil, Klaus Burkert, Holger Ottleben, Jurgen Gamer, Renate Sekul, Holger Deppe, Achim Feurer, Dirk Tomandl and Gunther Metz
DOI: 10.2174/157018005774717343
Identification of Privileged Scaffolds from a Diversified Chemical Library forβ-Secretase Inhibition
, 2(8): 595 - 600Nicolas Pietrancosta, Gilles Quelever, Cedrik Garino, Younes Laras, Stephane Burlet and Jean-Louis Kraus
DOI: 10.2174/157018005774717352
Synthesis and Biological Evaluation of 1,2,4-Triazolo[2,3-a]pyrrole Derivatives as Alpha-4 ( α4) Integrin Antagonists
, 2(8): 601 - 605Edward C. Lawson, William A. Kinney, Rosemary J. Santulli, Carol M. Fisher, Bruce P. Damiano and Bruce E. Maryanoff
DOI: 10.2174/157018005774717280
Szeged Index - Applications for Drug Modeling&#
, 2(8): 606 - 624Padmakar V. Khadikar, Sneha Karmarkar, Vijay K. Agrawal, Jyoti Singh, Anjali Shrivastava, Istvan Lukovits and Mircea V. Diudea
DOI: 10.2174/157018005774717334
Initial Structure-Activity Relationships for a Caprolactam-based Series of Neutral Factor Xa Inhibitors: Lead Identification
, 2(8): 625 - 630Gregory S. Bisacchi, Philip D. Stein, Jack Z. Gougoutas, Karen S. Hartl, R. Michael Lawrence, Eddie Liu, Andrew Pudzianowski, William A. Schumacher, Doree Sitkoff, Thomas E. Steinbacher, James Sutton, Zhaoxiao Zhang and Steven M. Seiler
DOI: 10.2174/157018005774717316
Synthesis and Evaluation of p-Nitrophenylβ-D-Glucopyranosiduronic Analogues as New Triggers for β-Glucuronidase Mediated Prodrug Mono- Therapy
, 2(8): 631 - 637Damien Combaud, Mickael Thomas, Sebastien Papot and Jean-Pierre Gesson
DOI: 10.2174/157018005774717271
Structure Based Design of Inhibitors of Aspartic Protease of HIV-1
, 2(8): 638 - 646V. Frecer, A. Jedinak, A. Tossi, F. Berti, F. Benedetti, D. Romeo and S. Miertus
DOI: 10.2174/157018005774717307
Editor-in-Chief
Ivana Cacciatore
Department of Pharmacy
University "G. d'Annunzio" of Chieti-Pescara
Chieti Scalo
(Italy)
Biography
Department of Pharmacy
University "G. d'Annunzio" of Chieti-Pescara
Chieti Scalo
Biography
Biography of Ivana Cacciatore
Prof. Ivana Cacciatore received her master’s degree in Pharmaceutical Chemistry and Technology in 1999 from the University of Chieti-Pescara (Italy). In 2002 she obtained her Ph.D. in Pharmaceutical Science. Currently, she is Associate Professor of Medicinal Chemistry at the Department of Pharmacy, University of Chieti-Pescara.
She is co-founder and member of the Board of Directors of the Spin Off Company "Algo Biotechnologies" holding the role of Chief Innovation Officer (CIO). Her research interests are drug design and discovery, medicinal chemistry, pharmacology, etc. Her research is well documented in more than 90 papers published in peer-reviewed international scientific Journals.
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Letters in Drug Design & Discovery was introduced in 2004. Dr. Kamil Kuca serves as the Editor-in-Chief of the journal.
Advertisement
Webmaster Contact: info@benthamscience.net